Search results
Author(s):
Rachel Lampert
Added:
3 years ago
The increased risk of drug-related torsades de pointes (TdP) and death in women taking ion-channel-active antiarrhythmic drugs was first described 20 years ago. In 1993, Makkar1 identified all case reports or case series of drug-related TdP, finding 332 patients described in 83 articles. The proportion of women versus men in these reported series was compared with the proportion of women versus…
View more
Author(s):
Neil Davidson
,
Julian Hobbs
Added:
3 years ago
The right and left atria are two complex cardiac chambers with the role of collecting venous blood from the body and the lungs, respectively, before contracting to augment the passive filling of the ventricles. This contraction is initiated and co-ordinated by the electrical conduction system of the heart. An important abnormality of heart rhythm is atrial fibrillation (AF), affecting 1–2% of the…
View more
Author(s):
Todd Rudo
Added:
3 years ago
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice, with a prevalence that substantially increases with age. Both the loss of atrial mechanical function and a rapid, irregular ventricular response contribute to potentially significant symptoms, including palpitations, fatigue, chest discomfort, light headedness or syncope. Additionally, AF is associated with a…
View more
Author(s):
Zenawit Girmatsion
,
Joachim R Ehrlich
Added:
3 years ago
Atrial fibrillation (AF) alters the function of the heart beyond mere changes in cardiac rhythm. It has been associated with untoward clinical outcomes in patients, such as the development of heart failure and stroke. Recent years have brought attention to several aspects of AF-associated alterations termed ‘remodelling’. This article will provide an overview of pertinent aspects of this subject…
View more
Author(s):
Markus Flesch
Added:
3 years ago
Introduction
Chronic heart failure (HF) is a common, malignant disease and is a major economic burden for healthcare systems in developed nations. It affects 5% to 10% of all people. In Germany, approximately 150,000 people are newly diagnosed with HF per year. Fifteen per cent of approximately 1.6 million HF patients in Germany are in advanced HF status, being classified as stage III-IV…
View more
Author(s):
Jason G Andrade
,
Ricky D Turgeon
,
Laurent Macle
,
et al
Added:
1 year ago
Novel Approaches for AF Ablation
Author(s):
Giulio La Rosa
,
Jorge G Quintanilla
,
Ricardo Salgado
,
et al
Added:
2 years ago
Article
Author(s):
Dipen Shah
Added:
3 years ago
Since the first description of catheter ablation for focally initiated atrial fibrillation and focal atrial fibrillation in 1995, the popularity of this catheter intervention has grown practically exponentially and the ablation strategy underlying the intervention has evolved considerably. From ‘point’ ablation within the pulmonary venous vasculature,1 ablation has progressed through circular…
View more